ClickCease
+ 1-915-850-0900 spinedoctors@gmail.com
Page Filifilia

E te aafia i faafitauli masani ole soifua maloloina ole soifua maloloina? Research studies have found that Parkinson’s disease (PD) may be associated with the gut-brain connection. Evidence in a group of mice demonstrated that PD can actually start in the gut, which may explain why patients with PD have constipation and other gut health issues. Scientists have also found that patients with Parkinson’s disease report having gut health issues up to 10 years before experiencing tremors and other symptoms. According to other research studies, patients with PD may even have different biodiversity of gut bacteria than other healthy adults. �

 

Outcome measures in the group of mice showed that the “harmful” alpha-synuclein fibers that build-up in the nerve cell endings of patients with Parkinson’s disease can immediately affect neurons in the brain. Scientists found this by identifying the spread of alpha-synuclein fibers in the nerve cell endings of the affected neurons in the brain of patients with PD. Alpha-synuclein is a fat-soluble substance, generally found in healthy neurons, however, alpha-synuclein molecules can clump together and damage brain cells. Scientists also found that patients can have a build-up of alpha-synuclein fibers in their gut. �

 

O le Gut-Brain Connection

A collection of fibers, known as the vagus nerve, which starts in the brain stem and extends to the major organs, including the gut, is believed to be the main source of PD associated with the gut-brain connection. Recent research studies of vagotomy patients demonstrated a reduced risk of developing Parkinson’s disease. Scientists have also found that alpha-synuclein fibers injected into the digestive system of a group of mice can reach the brain through the vagus nerve. If alpha-synuclein molecules can reach the brain from the gut, why does the fat-soluble substance build-up in the gut in the first place? �

 

Scientists believe that alpha-synuclein develops in the gastrointestinal (GI) tract to help combat pathogens and other “harmful” components. Michael Zasloff, a professor at Georgetown University, and his colleagues reported that alpha-synuclein molecules developed in healthy children after having an infection and alpha-synuclein seemed to trigger immune cells. Scientists also believe that alpha-synuclein can build-up in the GI tract due to the gut microbiome itself. Evidence in a group of mice demonstrated that bacteria can ultimately activate the development of alpha-synuclein in the gut and brain. �

 

Research studies have started to understand how the gut microbiome may be associated with Parkinson’s disease. Scientists have found that patients with Parkinson’s disease have a unique biodiversity of gut bacteria and scientists have also found that fecal microbe transplants from patients into a group of mice may increase alpha-synuclein in the brain and worsen symptoms in patients with PD. Other research studies have also shown that alpha-synuclein molecules seem to trigger microglial cells. This substance may send a signal through the vagus nerve or penetrate it completely through the bloodstream. �

 

Fula ma faʻamaʻi a Parkinson

According to several research studies, inflammation caused by an abnormal gut microbiome may also cause the development of Parkinson’s disease. In one research study, Inga Peter, a genetic epidemiologist at the Icahn School of Medicine at Mount Sinai, and her colleagues analyzed the relationship between inflammatory bowel syndrome (IBS) and Parkinson’s disease. The analysis compared 144,018 participants with ulcerative colitis or Crohn’s disease and 720,090 healthy controls where PD was 28 percent higher in people with IBS than in those in the control group, supporting previous research study findings. �

 

Inflammation is believed to increase the risk of developing Parkinson’s disease because it may increase alpha-synuclein as well as increase intestinal and blood-brain barrier (BBB) permeability. Inflammation may also increase cytokines, molecules which can increase inflammation in the body. Moreover, an abnormal gut microbiome can also cause inflammation. However, because not all patients with Parkinson’s disease will have inflammatory bowel syndrome or any other gut health issues, further evidence is still required to determine how the gut-brain connection can ultimately be associated with PD. �

 

If this is indeed true, however, it will allow scientists to develop new interventions for the treatment of Parkinson’s disease that targets the gut instead of the brain. Several research studies have already started to analyze the effects of these new interventions. In 2015, Michael Zasloff and his colleagues started a company, known as Enterin, which is currently testing a substance that decreases the development of alpha-synuclein molecules in the gastrointestinal (GI) tract. Although the treatment is intended to reduce constipation, the scientists hope that they will be able to prevent or even restore the effects of PD. �

 

Although many research studies and evidence support the hypothesis that Parkinson�s disease may be much closely associated with the gut-brain axis than we thought, the question of how early the digestive system changes may occur is still unknown. Furthermore, other scientists still suggest that PD may start elsewhere in the body. �I believe that there�s possibly various sites of origin for Parkinson�s disease,� stated Viviane Labrie, a neuroscientist at the Van Andel Research Institute in Michigan. �For several people, it might be the gut while for several people, it might simply be something that occurs in the brain.�

Dr. Alex Jimenez Insights Image

Parkinson’s disease (PD) is a movement disorder that affects the central nervous system. PD can cause various, well-known symptoms, including tremors, slowed movements, stiffness, and loss of balance, among others. Research studies have demonstrated that nerve cell damage in the brain can decrease dopamine, a neurotransmitter and/or hormone, that can cause Parkinson’s disease. However, scientists have found that the gut-brain connection may ultimately be associated with PD. Inflammation caused by an abnormal gut microbiome as well as gut health issues like irritable bowel syndrome (IBS) is also believed to be one of the main factors for PD associated with the gut-brain connection.�- Dr. Alex Jimenez D.C., C.C.S.T. Insight

 

O le lautele o a tatou faʻamatalaga e faʻamapulaʻa i fomaʻi, musikalokeletal, ma mataupu tau le soifua maloloina o le tino poo mataupu tau vailaʻau faʻaleafugaga, autu, ma talatalanoaga. Matou te faʻaogaina togafitiga faʻalesoifua maloloina e togafitia ai manuʻa poʻo faʻalavelave o le masukulekelet system. O lo matou ofisa ua faia se taumafaiga talafeagai e tuʻuina atu faʻamaoniga lagolago ma ua faʻamaonia suʻesuʻega suʻesuʻega talafeagai poʻo suʻesuʻega e lagolago ai o matou pou. Matou te faia foi ni kopi o suʻesuʻega suʻesuʻe suʻesuʻe e avanoa i le komiti poʻo le lautele pe a talosagaina. Ina ia toe talanoaina le mataupu o loʻo i luga, faamolemole ia lagona le saolotoga e fesili atu ia Dr. Alex Jimenez pe faʻafesoʻotaʻi mai i matou 915-850-0900.

 

Faʻatautaia e Dr.Alex Jimenez

 

mau:

  • Johns Hopkins University School of Medicine. �New Research Shows Parkinson’s Disease Origins in the Gut.� Fomaʻi Faʻamatalaga - Faʻamatalaga Faʻapitoa mo Suesuega ma le Soifua Maloloina, Mental Health, 26 Iuni 2019, medicalxpress.com/news/2019-06-parkinson-disease-gut.html.
  • CureParkinsonsTrust. �New Evidence Suggests Parkinson’s Might Not Start in The Brain.� Le faʻamoemoe a le Cure Parkinson, 28 Nov.2019, www.cureparkinsons.org.uk/news/parkinsons-starts-in-gut.
  • Kwon, Diana. �Does Parkinson’s Begin in the Gut?� Scientific American, Scientific American, 8 Me 2018, www.scientificamerican.com/article/does-parkinsons-begin-in-the-gut/.

 


 

Neurotransmitter Assessment Form

 

Lenei Neurotransmitter Iloiloga Pepa mafai ona faʻatumuina ma tuʻuina atu ia Dr. Alex Jimenez. O faʻailoga nei o loʻo lisiina atu i lenei pepa e le fuafuaina e faʻaaoga e fai ma faʻamaoniga o soʻo se ituaiga o faʻamaʻi, tulaga, poʻo seisi lava ituaiga faʻafitauli tau soifua maloloina.

 


 

Fautuaga Lautele Talatalanoaga: Faʻanatinati Faʻanoanoa

O le faʻafuaseʻi o le tiga o se tali masani lea o le faʻaoga o le tino lea e fesoasoani e faʻaalia ai le manua. E ala i se faʻataʻitaʻiga, o faʻamaumauga o tiga e malaga mai se itulagi ua afaina e ala i neura ma le vaʻalaʻau i le faiʻai. O le tiga e masani lava ona itiiti le ogaoga pe a faʻamalolo le manuʻa, ae ui i lea, o le tiga masani e ese nai lo le ituaiga o tiga. Faʻatasi ai ma le tiga tumau, o le tino o le tagata o le a faʻaauau pea ona tuʻuina atu faailo o le tiga i le faiʻai, e tusa lava pe faʻamalolo le manuʻa. O tiga tiga e mafai ona tumau mo ni nai vaiaso i ni nai tausaga. O tiga faʻasolo e mafai ona matua afaina ai le gasegase o se tagata maʻi ma e mafai ona faʻaitiitia ai le gafatia, malosi, ma le tumau.

 

 


 

Neural Zoomer Plus mo le Neurological Disease

Neural Zoomer Plus | El Paso, TX Chiropractor

 

O Dr. Alex Jimenez e faʻaaogaina se tele o suʻega e fesoasoani e iloilo ai faʻamaʻi neuro. O le Neural ZoomerTM E sili atu foʻi le faʻavasegaina o fuamomo gaʻo neurological lea e maua ai le faʻamaoniga patino o le antibody-to-antigen. O le Vibrant Neural ZoomerTM Plus ua fuafuaina e iloilo se tasi gaioiga i le 48 neurological antigens ma fesoʻotaʻiga i le tele o faʻafitauli neurologically fesoʻotaʻi. Le Vibrant Neural ZoomerTM Plus faʻamoemoe e faʻaititia neula tulaga e ala i le faʻamalosia o tagata mamaʻi ma fomaʻi ma se taua punaoa mo vave lamatiaga mauaina ma se faʻalauteleina le taulaʻi i le tagata lava ia muamua puipuiga.

 

Faʻaaogofie Meaʻai mo le IgG & IgA Immune Response

Sensitivity Mea Taumafa Faʻamolemole | El Paso, TX Chiropractor

 

O Dr. Alex Jimenez e faʻaaogaina le tele o suʻega e fesoasoani e iloilo ai mataupu tau soifua maloloina e fesoʻotai ma meaʻai. Le Sensitivity Food SetupTM o se faʻasologa o le 180 masani ona faʻaumatia antigens meaʻai e ofaina ai le faʻatauaina o le antibody-to-antigen. Lenei vaega fuaina ai le tasi IgG ma IgA maʻaleʻale i meaai antigens. O le mafai ona faʻataʻitaʻi IgA anticodies e faʻaopoopo ai faʻamatalaga i meaʻai e ono mafua ai le faʻaleagaina o le mucosal. E le gata i lea, o lenei suʻega e lelei mo tagata mamaʻi oe ono pagatia mai le tuai ona tali atu i nisi o meaʻai. Faʻaaogaina se vailaʻau-faʻavae fualaʻau lagona lelei tofotofoga mafai ona fesoasoani faʻamuamua ia manaʻomia meaʻai e aveʻese ma fausia se tuʻuina i le taumafataga peleni faʻapitoa i le tagata maʻi manaʻoga manaʻoga.

 

Gut Zoomer mo le Vaʻa Faʻamaʻi Papatino Laititi (SIBO)

Gut Zoomer | El Paso, TX Chiropractor

 

Dr. Alex Jimenez e faʻaaogaina se tele o suʻega e fesoasoani ai e iloilo le soifua maloloina o loʻo aʻafia ma le faʻamaʻi pipisi o le intestinal bacterial overgrowth (SIBO). O le Vibrant Gut ZoomerTM ofaina se lipoti e aofia ai meaʻai faʻalautelega ma isi faʻalautelega faʻaopopo pei prebiotics, probiotics, ma polyphenols. O le microbiome o le manava e masani lava ona maua i totonu o le puta lapoʻa ma e sili atu ma le 1000 ituaiga o siama e taua tele i le tino o le tagata, mai le fausiaina o le immune system ma aʻafia ai le metabolism o meaʻai e faʻamalosia ai le alatoto mucosal papala ). E taua le malamalama pe faʻafefea e le numera o siama o loʻo ola faʻasolosolo i le tagata gastrointestinal (GI) tract ona afaina ai le soifua maloloina ona o le le paleni i le manava o le microbiome e ono iʻu ai lava i gastrointestinal (GI) auala o faʻailoga, tulaga o le paʻu, faʻafitauli o le autoimmune, faʻaletonu o le puipuiga o le tino. , ma le tele o faʻafitauli pipili.

 


Dunwoody Labs: Faleoloa Mataʻutia ma le Faʻatauga | El Paso, TX Chiropractor


GI-MAP: GI Microbial Assay Plus | El Paso, TX Chiropractor


 

Fua Faatatau mo le Methylation Support

Xymogen Formulas - El Paso, TX

 

XYMOGEN's Ole Polokalame Tomai Faapitoa e avanoa e ala i le filifilia o tagata tomai faapitoa ile soifua maloloina. Ole faʻatau ile initaneti ma le faʻaititia o XYMOGEN faʻataʻitaʻiga e matua faʻasaina.

Faamaualuga, Dr. Alexander Jimenez faia faʻataʻitaʻiga XYMOGEN na o maʻi i lalo o la matou tausiga.

Faʻamolemole valaʻau i le matou ofisa ina ia matou tofia se fomaʻi mo faʻamatalaga vave.

Afai o oe o se tagata maʻi Manua Fomaʻi & Chiropractic Clinic, e mafai ona e fesili e uiga i le XYMOGEN ile valaʻau 915-850-0900.

xymogen el paso, tx

Mo lou faigofie ma iloiloga o le XYMOGEN oloa faamolemole toe iloilo le sootaga lea. *XYMOGEN-Catalog-Download

 

* O aiaiga uma o XYMOGEN o loʻo i luga e tumau pea le faʻamalosia.

 


 


 

Faʻasoifua Faʻasoifua Faʻaonapo Nei

O le Iunivesite Aoao o le Soifua Maloloina Saienisi o se faʻalapotopotoga e ofaina le tele o ituaiga faʻamanuiaga matata i tagata auai. Tamaiti aʻoga mafai ona faʻataʻitaʻia lo latou naunau mo le fesoasoani i isi tagata ia mauaina le soifua maloloina lautele ma le soifua maloloina e ala i le faʻalapotopotoga misiona. O le Iunivesite Aoao o le Soifua Maloloina Saienisi saunia tamaiti aʻoga e avea ma taʻimua i luma o vailaʻau tuʻufaʻatasi vailaʻau, e aofia ai togafitiga faʻafomaʻi. Tamaiti aʻoga maua se avanoa e maua ai le mafaatusalia poto masani i le Iunivesite Aoao o le Soifua Maloloina Saienisi e mafai ai ona fesoasoani toe faʻaleleia le natura faʻamaoni o le onosaʻi ma faʻamatalaina le lumanaʻi o aso nei tuʻufaʻatasi vailaʻau.

 

 

Faʻataʻitaʻiga Tomai o Faʻataʻitaʻiga

O faʻamatalaga o loʻo i luga "Neurology Lelei: O le Fesootaiga Gut-Brain i le Diseinsoninson's Disease"E le o fa'amoemoe e sui ai se mafutaga ta'ito'atasi ma se fa'apolofesa fa'alesoifua maloloina agava'a po'o se foma'i laiseneina ma e le o se fautuaga fa'afoma'i. Matou te fa'amalosia oe e fai fa'ai'uga fa'alesoifua maloloina e fa'atatau i au su'esu'ega ma faiga fa'apaaga ma se tagata tomai fa'apitoa tau soifua maloloina.

Blog Fa'amatalaga & Va'aiga Talanoaga

O matou fa'amatalaga lautele e fa'atapula'a ile Chiropractic, musculoskeletal, vaila'au fa'aletino, soifua maloloina, fa'asoa etiological fa'alavelave viscerosomatic i totonu o fa'ata'ita'iga fa'apitoa, somatovisceral reflex fa'ata'ita'iga fa'amanino, fa'alavelave fa'aletonu, fa'afitauli ma'ale'ale o le soifua maloloina, ma/po'o tala fa'afoma'i aoga, autu, ma talanoaga.

Matou te tuuina atu ma tuuina atu felagolagomai falema'i faatasi ai ma tagata tomai faapitoa mai matata eseese. O fa'apitoa ta'ito'atasi e fa'atonutonuina e la latou fa'apolofesa lautele o fa'ata'ita'iga ma a latou pulega fa'atulafonoina. Matou te fa'aogaina tulafono fa'alesoifua maloloina ma le soifua manuia e togafitia ma lagolago ai le tausiga o manu'a po'o fa'aletonu o le musculoskeletal system.

O a matou vitiō, pou, mataupu, mataupu, ma malamalamaga e aofia ai mataupu tau falemaʻi, mataupu, ma mataupu e fesoʻotaʻi ma tuusaʻo pe le tuusaʻo le lagolagoina o la matou faʻataʻitaʻiga masani.*

O lo matou ofisa sa taumafai lava e tu'uina atu fa'amatalaga lagolago ma ua fa'ailoa mai su'esu'ega su'esu'ega talafeagai po'o su'esu'ega e lagolagoina a matou pou. Matou te saunia ni kopi o lagolagoina suʻesuʻega suʻesuʻega avanoa i tulafono faʻatonutonu laupapa ma tagata lautele pe a talosagaina.

Matou te malamalama o matou aofia ai mataupu e manaʻomia se faʻaopopo faʻamatalaga o le auala e ono fesoasoani ai i se faʻapitoa tausiga fuafuaga poʻo togafitiga togafitiga; o lea, ia toe talanoaina le mataupu mataupu i luga, faʻamolemole lagona le saoloto e fesili Dr. Alex Jimenez, DC, pe faʻafesoʻotaʻi i matou 915-850-0900.

Ua matou o mai e fesoasoani ia oe ma lou aiga.

faamanuiaga

Dr. Alex Jimenez D.C., MSACP, RN*, CCST, IFMCP*, CIFM*, atn*

imeli: faiaoga@elpasofunctionalmedicine.com

Laisene o se Fomaʻi o Chiropractic (DC) i Texas & New Mexico*
Texas DC Laisene # TX5807, New Mexico DC Laisene # NM-DC2182

Laisene ose Tausima'i Resitala (RN*) in Florida
Florida Laisene RN Laisene # RN9617241 ( Pule Nu. 3558029)
Tulaga Fa'atasi: Laisene Tele-Setete: Fa'atagaina e Fa'ata'ita'i i totonu 40 States*

Dr. Alex Jimenez DC, MSACP, RN* CIFM*, IFMCP*, ATN*, CCST
La'u Pepa Pisinisi Digital